|4Jan 6, 5:10 PM ET

FROM STEPHEN 4

4 · KIORA PHARMACEUTICALS INC · Filed Jan 6, 2022

Insider Transaction Report

Form 4
Period: 2022-01-05
FROM STEPHEN
DirectorPresident and CEO
Transactions
  • Tax Payment

    Common Stock

    2022-01-05$1.08/sh326$35267,693 total
Footnotes (1)
  • [F1]Sale of shares to cover taxes due on restricted stock that vested on 01/01/2022.

Documents

1 file
  • 4
    tm222161-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT